First-in-human Phase I studies of PRS-080#22, a hepcidin antagonist, in healthy volunteers and patients with chronic kidney disease undergoing hemodialysis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
First-in-human Phase I studies of PRS-080#22, a hepcidin antagonist, in healthy volunteers and patients with chronic kidney disease undergoing hemodialysis
Authors
Keywords
Chronic kidney disease, Medical dialysis, Anemia, Ferritin, Pharmacodynamics, Adjustment of dosage at steady state, Adverse reactions, Pharmacokinetics
Journal
PLoS One
Volume 14, Issue 3, Pages e0212023
Publisher
Public Library of Science (PLoS)
Online
2019-03-28
DOI
10.1371/journal.pone.0212023
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemia
- (2017) Saroj Vadhan-Raj et al. Journal of Hematology & Oncology
- Serum Hepcidin and Iron Indices Affect Anemia Status Differently According to the Kidney Function of Non-Dialysis Chronic Kidney Disease Patients: Korean Cohort Study For Outcome in Patients with Chronic Kidney Disease (KNOW-CKD)
- (2017) Sung Woo Lee et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Safety, pharmacokinetics and pharmacodynamics of the anti-hepcidin Spiegelmer lexaptepid pegol in healthy subjects
- (2016) M Boyce et al. BRITISH JOURNAL OF PHARMACOLOGY
- Increased serum hepcidin contributes to the anemia of chronic kidney disease in a murine model
- (2016) Mark R. Hanudel et al. HAEMATOLOGICA
- Increased serum hepcidin contributes to the anemia of chronic kidney disease in a murine model
- (2016) Mark R. Hanudel et al. HAEMATOLOGICA
- Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women
- (2015) D. Moretti et al. BLOOD
- Considerations and Challenges in Defining Optimal Iron Utilization in Hemodialysis
- (2014) D. M. Charytan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Prevalence of Anemia in Chronic Kidney Disease in the United States
- (2014) Melissa E. Stauffer et al. PLoS One
- Hepcidin-25 Concentrations Are Markedly Increased in Patients With Chronic Kidney Disease and Are Inversely Correlated With Estimated Glomerular Filtration Rates
- (2013) Jason S. Troutt et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Hemodialysis-associated Hemosiderosis in the Era of Erythropoiesis-stimulating Agents: A MRI Study
- (2012) Guy Rostoker et al. AMERICAN JOURNAL OF MEDICINE
- Hepcidin and iron homeostasis
- (2012) Tomas Ganz et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Diurnal Rhythm rather than Dietary Iron Mediates Daily Hepcidin Variations
- (2012) C. C. M. Schaap et al. CLINICAL CHEMISTRY
- Circulating Human Hepcidin-25 Concentrations Display a Diurnal Rhythm, Increase with Prolonged Fasting, and Are Reduced by Growth Hormone Administration
- (2012) J. S. Troutt et al. CLINICAL CHEMISTRY
- Closing the Iron Gate
- (2012) Nancy C. Andrews NEW ENGLAND JOURNAL OF MEDICINE
- Hepcidin is a Potential Regulator of Iron Status in Chronic Kidney Disease
- (2012) Ken Tsuchiya et al. THERAPEUTIC APHERESIS AND DIALYSIS
- Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation
- (2011) Chia Chi Sun et al. AMERICAN JOURNAL OF HEMATOLOGY
- Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice
- (2011) Emilio Ramos et al. HEPATOLOGY
- Serum ferritin: Past, present and future
- (2010) Wei Wang et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Immunochemical and Mass-Spectrometry-Based Serum Hepcidin Assays for Iron Metabolism Disorders
- (2010) J. J. C. Kroot et al. CLINICAL CHEMISTRY
- Resolved: Targeting a Higher Hemoglobin Is Associated with Greater Risk in Patients with CKD Anemia: Pro
- (2009) A. K. Singh et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Iron Sequestration and Anemia of Inflammation
- (2009) Tomas Ganz et al. SEMINARS IN HEMATOLOGY
- Aspects of Immune Dysfunction in End-stage Renal Disease
- (2008) S. Kato et al. Clinical Journal of the American Society of Nephrology
- Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products
- (2008) Gopi Shankar et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started